Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 Month Period

Collegium Antropologicum

Volumn 34, Issue 3, 2010, Pages 847-852

  Suić, Smiljka Popović ^a,b   Lauš, Katia Novak ^c   Došen, Vukosava Maričič ^d   Ekert, Miroslav ^e   Mandić, Zdravko ^c   Bojić, Lovro ^f  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Croatian Academy of Medical Sciences   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

^f UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Dosing regimen; Glaucoma; Travoprost 0.004 timolol 0.5

Indexed keywords

CLOPROSTENOL; DRUG DERIVATIVE; TIMOLOL; TRAVOPROST; DRUG COMBINATION;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GLAUCOMA, OPEN-ANGLE;

CLOPROSTENOL; DRUG COMBINATIONS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; PROSPECTIVE STUDIES; TIMOLOL;

EID: 77957911402     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. CHEN PP Ophtalmology, 110 (2003) 726.
2. HATTENHAUER MG, JOHNSON DH, ING HH, Ophtalmology, 105 (1998) 2099.
3. LESKE MC, HEIJL A, HYMAN L, BENGTSSON B, Ophtalmology, 106 (1999) 2144.
4. MUSCH DC, GILLESPIE BW, NIZIOL LM, CASHWELL LF, LICHTER PR, Ophtalmology, 114 (2007) 1965.
5. MORLEY AM, MURDOCH I, Br J Ophtalmol, 90 (2006) 640.
6. STEWARD WC, GARRISON PM, Arch Intern Med, 158 (1998) 221.
7. TSAI JC, McCLURE CA, RAMOS SE, SCHLUNDT DG, PICHERT JW, J Glaucoma, 12 (2003) 393.
8. LeBLANC RP, KRIP G, Ophtalmology, 88 (1981) 244.
9. ZIMMERMAN TJ, KAUFMAN HE, Arch Ophtalmol, 95 (1981) 601.
10. REISS GR, BRUBAKER RF, Ophtalmology, 90 (1983) 1369.
11. SHARIF NA, KELLY CR, CRIDER JY, Invest Ophtalmol Vis Sci, 44 (2003) 715.
12. SHARIF NA, CRIDER JY, HUSAINS, KADDOUR-DJEBBAR I, ANSATIAR, ABDEL-LATIF AA, J Ocular Pharm Ther, 19 (2003) 437.
13. BRUBAKER RF, SCHOFF EO, NAU CB, CARPENTER SP, CHEN K, VANDENBURGH AM, Am J Ophtalmol, 131 (2001) 19.
14. NETHLAND PA, LANDRY T, SULLIVAN EK, ANDREW R, SILVER L, WEINER A, MALICK S, DICKERSON J, BERGAMINI MV, ROBERTSON SM, DAVIS AA, Am J Ophtalmol, 132 (2001) 472.
15. FELLMAN RL, SULLIVAN EK, RATLIFF M, Ophtalmology, 109 (2002) 998.
16. KASS MA, HEUER DK, HIGGINBOTHAM EJ, Arch Ophtalmol, 120 (2002) 701.
17. WEINREB RN, J Glaucoma, 1 (1992) 134.
18. OREGO-NANIA S, LANDRY T, VON-TRESS M, Am J Ophtalmol, 132 (2001) 860.
19. HIGGINBOTHAM EJ, FELDMAN R, STILES M, Arch Ophtalmol, 120 (2002) 15.
20. AREND KO, BABER T, J Ocul Pharm Ther, 24 (2008) 414.
21. BARNABY H, ORENGO-NANIA S, FLOWERS BE, Am J Ophtalmol, 140 (2005) 1.
22. HOMMER A, Eur J Ophtalmol, 17 (2007) 53.
23. HUGHES BA, BACHARACH J, CRAVEN ER. J Glaucoma, 14 (2005) 392.
24. BRANDT JD, BEISER JA, KASS MA, GORDON MO, Ophtalmology, 108 (2001) 1779.
25. The AGIS INVESTIGATORS, Am J Ophtalmol, 130 (2000) 429.
26. ALM A, STJER-NSCHANTZ J, Ophtalmology, 102 (1995) 1743.
27. KONSTAS AG, NAKOKS E, TERSIS I, Am J Ophtalmol, 133 (2002) 753.
28. DENIS P ANDREW R, WELLS D, FRIREN N, Eur J Ophtalmol, 16 (2006) 407.
29. PATEL SC, SPAETH GL, Ophtalmic Surg, 26 (1995) 233.
30. SILVERMAN SL, Am J Med, 122 (2009) 122.